Resources from the same session
2963 - A Personal Neoantigen Vaccine, NEO-PV-01, with anti-PD1 Induces Broad De Novo Anti-Tumor Immunity in Patients with Metastatic Melanoma, NSCLC, and Bladder Cancer
Presenter: Patrick Ott
Session: Proffered paper session - Immunotherapy of Cancer
Resources:
Abstract
Slides
Webcast
2132 - Pre-specified interim analysis of a randomized phase 2b trial of trastuzumab + nelipeptimut-S (NeuVax) vs trastuzumab for the prevention of recurrence demonstrates benefit in triple negative (HER2 low-expressing) breast cancer patients
Presenter: Daine Hale
Session: Proffered paper session - Immunotherapy of Cancer
Resources:
Abstract
Slides
Webcast
2717 - Stage 2 enrollment complete: Sitravatinib in Combination with Nivolumab in NSCLC Patients Progressing on Prior Checkpoint Inhibitor Therapy
Presenter: Ticiana Leal
Session: Proffered paper session - Immunotherapy of Cancer
Resources:
Abstract
Slides
Webcast
4747 - Responses and Durability of Clinical Benefit in Renal Cell Carcinoma Treated with Pegilodecakin in Combination With Anti-PD-1 Inhibitors
Presenter: Aung Naing
Session: Proffered paper session - Immunotherapy of Cancer
Resources:
Abstract
2621 - Neoadjuvant ipilimumab plus nivolumab in early stage colon cancer
Presenter: Myriam Chalabi
Session: Proffered paper session - Immunotherapy of Cancer
Resources:
Abstract
Slides
Webcast
Proffered paper session - Immunotherapy of Cancer - Invited Discussant LBA37_PR and 1127O
Presenter: George Coukos
Session: Proffered paper session - Immunotherapy of Cancer
Resources:
Slides
Webcast